Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics
Top Cited Papers
- 1 October 2007
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 7 (10) , 750-762
- https://doi.org/10.1038/nrc2230
Abstract
Mantle cell lymphoma (MCL) is a well-defined lymphoid malignancy characterized by a rapid clinical evolution and poor response to current therapeutic protocols. The genetic and molecular mechanisms involved in its pathogenesis combine the dysregulation of cell proliferation and survival pathways with a high level of chromosome instability that seems related to the disruption of the DNA damage response pathway. Understanding these mechanisms and how they affect tumour behaviour is providing the rationale for the identification of reliable predictors of clinical evolution and the design of innovative therapeutic strategies that could open new avenues for the treatment of patients with MCL.Keywords
This publication has 129 references indexed in Scilit:
- Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survivalBlood, 2007
- Specific Secondary Genetic Alterations in Mantle Cell Lymphoma Provide Prognostic Information Independent of the Gene Expression–Based Proliferation SignatureJournal of Clinical Oncology, 2007
- The impact of translocations and gene fusions on cancer causationNature Reviews Cancer, 2007
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drugNature Biotechnology, 2007
- Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activityBlood, 2006
- Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphomaBlood, 2006
- Mantle cell lymphomas with clonal immunoglobulin V3–21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V genesLaboratory Investigation, 2005
- Spatial proximity of translocation-prone gene loci in human lymphomasNature Genetics, 2003
- Cyclin D1/PRAD1/BCL-1 alternative transcript [B] protein product in B-lymphoid malignancies with t(11;14)(q13;q32) translocationInternational Journal of Cancer, 1999